Kas Dan Setara Perubahan Tanggal
AbbVie USD 6.57B 2.82B 2026-06
Agenus USD 18.74M 16.26M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.75B 46.02M 2026-09
Amgen USD 13.99B 1.95B 2026-06
Astellas Pharma JPY 281.6B 93.23B 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
Biogen USD 1.3B 18.9M 2026-09
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Eli Lilly USD 4.89B 4.07B 2026-09
Gilead Sciences USD 3.18B 4.45B 2026-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
Incyte USD 3.85B 127.8M 2026-09
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 16.91B 3.51B 2026-09
Kyowa Hakko Kirin JPY 218.77B 15.83B 2025-12
Merck USD 6.85B 1.52B 2026-06
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Pfizer USD 976M 727M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 3.66B 1.2B 2026-09
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 5.54B 2.11B 2026-03
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
United Therapeutics USD 1.8B 523.5M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06